NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)NovartisPhase 1 Completed283 enrolled
NCT00101972 2022-02-22RAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaMacroGenicsPhase 1 Completed53 enrolled
NCT00003002 2019-02-27HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerUniversity of WashingtonPhase 1 Completed60 enrolled
NCT02485119 2018-06-04Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced MalignanciesBayerPhase 1 Completed12 enrolled
NCT00005023 2017-11-30Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV CancerUniversity of WashingtonPhase 1 Completed